Wajdy Al-Awaida

Dr. Wajdy Al-Awaida

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2018 in Nutrition and Cancer
Verified
Journal Article
Closed access
MAMuayad Mehdi Abboud
Muayad Mehdi Abboud
WAWajdy Al-Awaida
Wajdy Al-Awaida
HAHakam Hasan Alkhateeb
Hakam Hasan Alkhateeb
AAAsia Numan Abu-Ayyad
Asia Numan Abu-Ayyad
The treatment of MCF-7 and T47D human breast cancer cell lines with amygdalin was able to reduce the growth of both cells, in concentration and time-dependent manners. The potency of this inhibition against MCF-7 and T47D cells produced IC50 values of 39 and 45 mM, respectively. To investigate the correlation of this inhibition with oxidative stress, an amygdalin treatment of both cell lines was capable of inducing the generation of malondialdehyde (MDA) and oxidized glutathione levels. Also, this treatment caused the decrease of total glutathione and glutathione reductase activity. The proportional survival of tumor cells from this inhibition was positively correlated with the total glutathione, but it was inversely correlated with amygdalin or MDA levels (P < 0.001). In MCF-7 cells, the production of total glutathione was six times higher in the untreated than in amygdalin-treated cells, whereas this difference was reduced to 2.1 times in the T47D cells. Similarly, the production of MDA in MCF-7 cells was 2.4 times higher in the amygdalin-treated than in the untreated cultures, which were lowered to 1.3 times in the T47D cells. These data support a mechanism of amygdalin antitumor action against breast cancer cells based on the induction of oxidative stress.

20 April 2021 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
AIAmer Imraish
Amer Imraish
TTTuqa Abu Thiab
Tuqa Abu Thiab
WAWajdy Al-Awaida
Wajdy Al-Awaida
Hamzeh J. Al-AmeerHamzeh J. Al-Ameer
Hamzeh J. Al-Ameer
YBYasser Bustanji
Yasser Bustanji
AAAfnan Al-Hunaiti
Afnan Al-Hunaiti

24 February 2020 in npj Microgravity
Verified
Journal Article
Open access
WAWajdy Al-Awaida
Wajdy Al-Awaida
ASAhmad S. Sharab
Ahmad S. Sharab
HAHamzeh J. Al-Ameer
Hamzeh J. Al-Ameer
NANabil Y. Ayoub
Nabil Y. Ayoub
Microgravity affects plant growth and content. A three-dimensional clinostat was used at 4 rotations/min to rotate the seeds of Triticum aestivum cultivar (Ammon) in three dimensions for 7 days, following which the antioxidant activities of ethanolic extracts were evaluated using both nitric oxide- and hydrogen peroxide-scavenging activities. The antidiabetic activities of ethanolic extracts were evaluated by measuring the concentration of plasma glucose, insulin, C peptide, and glycated hemoglobin (HbA1c); determining the number of β cells in the pancreatic islets; and performing the glucose tolerance test. Furthermore, the effects of the ethanolic extracts on the lipid profile and liver function were estimated. After rats were sacrificed, their pancreases were isolated and used for histopathological processing. The results indicated that the antioxidant potential and antioxidant metabolite content were significantly increased under microgravity conditions in comparison to those under normal gravity conditions. Rats treated with an extract of wheatgrass (T. aestivum) germinated over a period of 6–10 days under microgravity (WGM) showed a significant reduction in the levels of serum glucose, HbA1C, urea, creatinine, aspartate aminotransferase and alanine aminotransferase, and insulin resistance compared to rats treated with an extract of wheatgrass germinated under gravity. Additionally, the total cholesterol and low-density lipoprotein cholesterol levels were significantly decreased. In contrast, high-density lipoprotein cholesterol, C-peptide, and insulin levels rose significantly after treatment with T. aestivum germinated under microgravity. WGM is a promising potential diabetic treatment without side effects with a low manufacturing cost.

9 December 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SZSima Zein
Sima Zein
SASarah B. Abdallah
Sarah B. Abdallah
AAAhmed Al-smadi
Ahmed Al-smadi
OGOmar Gammoh
Omar Gammoh
WAWajdy Al-Awaida
Wajdy Al-Awaida
HAHanan J. Al-Zein
Hanan J. Al-Zein
Background: The COVID-19 pandemic is expected to continue to inflect immense burdens of morbidity and mortality, not to mention the sever disruption of societies and economies worldwide. One of the major challenges to managing COVID-19 pandemic is the negative attitudes towards vaccines and the uncertainty or unwillingness to receive vaccinations. We evaluated the predictors and factors behind the negative attitudes towards COVID-19 vaccines in 3 countries in the Middle East. Methods: A cross-sectional, self-administered survey was conducted between the 1st and the 25th of December, 2020. Representative sample of 8619 adults residing in Jordan, West Bank, and Syria, completed the survey via the Web or via telephone interview. The survey intended to assess intent to be vaccinated against COVID-19 and to identify predictors of and reasons among participants unwilling/hesitant to get vaccinated. Results: The total of the 8619 participants included in this study were the ones who answered the question on the intent to be vaccinated. Overall, 32.2% of participants (n = 2772) intended to be vaccinated, 41.6% (n = 3589) didn’t intend to get vaccinated, and 26.2% (n = 2258) were not sure. The main factors associated with the willingness to take the vaccine (yes responses) included females, 18–35 years old, Syrians and Jordanians, a large family size, and having received a flu vaccine last year. Reasons for vaccine hesitancy included the lack of rigorous evaluation of the vaccine by the FDA and the possible long-term health risks associated with the vaccines (the wait-and-see approach). Conclusion: This survey, conducted in December when the number of cases and deaths per day due to COVID-19 were at or near peak levels of the initial surge in the three regions under investigation. The survey revealed that most of survey’s participants (67.8%) were unwilling/hesitant to get vaccinated against COVID-19 with the lack of trust in the approval process of the vaccine being the main concern; the two main characteristics of those participants were more than 35 years old and participants holding a Bachelor’s degree or higher. Targeted and multi-pronged efforts will be needed to increase acceptance of COVID-19 vaccine in Jordan, West Bank and Syria.

1 October 2018 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
WAWajdy Al-Awaida
Wajdy Al-Awaida
BABaker Jawabrah Al-Hourani
Baker Jawabrah Al-Hourani
MAMuhanad Akash
Muhanad Akash
Wamidh TalibWamidh Talib
Wamidh Talib
SZSima Zein
Sima Zein
ZAZaid Aburubaiha
Zaid Aburubaiha
Purpose: The goal of our study is to test whether a naturally occurring plant, Ephedra aphylla, will show antiproliferative ability against tested cell lines and to test its anti-inflammatory and antioxidative potentials. Materials and Methods: In our study, we used four solvents with different polarities – aqueous, chloroform, methanol, and n-hexane – to extract different compounds from the aerial parts of E. aphylla. Antioxidant activity of E. aphylla was determined by measuring nitric oxide (NO) and hydrogen peroxide (H 2 O 2 ) scavenging activities. The anti-inflammatory activity was studied using the inhibition of albumin denaturation assay. Finally, the antiproliferative activity of breast cancer cell lines (T47D, MCF-7) and Vero cell line (African green monkey kidney) was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results: Phytochemical screening for various extracts of E. aphylla showed the presence of medicinally important compounds including cardiac glycosides, alkaloids, triterpenes, tannins, and flavonoids. The scavenging activity for H 2 O 2 of various solvent extracts was in the order of methanol > aqueous > chloroform > ethyl acetate > n-hexane. In addition, E. aphylla solvent extracts also exhibited a scavenging activity for NO in the order of methanol > ethyl acetate > aqueous > chloroform > n-hexane. All of the solvent extracts showed IC 50 inhibition of albumin denaturation at a concentration between 209.5 ± 8.1 and 225 ± 11 μg/ml. Moreover, all extracts displayed strong antiproliferative potential against MFC7, T47D tested cell lines and very weak cytotoxic activity against Vero normal cell line. Conclusions: E. aphylla has a promising potential to be used as a drug source for breast cancer treatment based on its strong antiproliferative activity.

1 October 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BABaker Jawabrah Al-Hourani
Baker Jawabrah Al-Hourani
WAWajdy Al-Awaida
Wajdy Al-Awaida
KMKhalid Matalka
Khalid Matalka
MEMusa I. El-Barghouthi
Musa I. El-Barghouthi
FAFatima Alsoubani
Fatima Alsoubani
FWFrank Wuest
Frank Wuest